How people with CF access CFTR modulators in countries where coverage is not provided by health systems
Use of Elexacaftor/Tezacaftor/Ivacaftor in Pregnant Mothers without CF to Treat Meconium Ileus in Fetuses with Cystic Fibrosis
Understanding rates of and factors associated with elexacaftor/tezacaftor/ivacaftor (ETI) prescription
A study on how the newest modulator medication elexacaftor/tezacaftor/ivacaftor affects the gut over time using MRI scans
Evaluating the Effectiveness of a Novel CF Medication for People Without Common Cystic Fibrosis-causing Genetic Mutations
